Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Boniva ibandronate musculoskeletal data

In the double-blind MOTION study in 1,760 postmenopausal women with osteoporosis, 150 mg of once-monthly Boniva met the primary endpoint of

Read the full 211 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE